 | • レポートコード：QYR2104Z5940 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ウイルスベクター＆プラスミドDNAのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（プラスミドDNA、ウイルスベクター）、用途別市場規模（がん、ウイルス感染、遺伝性疾患）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ウイルスベクター＆プラスミドDNAの市場動向 ・企業の競争状況、市場シェア ・ウイルスベクター＆プラスミドDNAの種類別市場規模（プラスミドDNA、ウイルスベクター） ・ウイルスベクター＆プラスミドDNAの用途別市場規模（がん、ウイルス感染、遺伝性疾患） ・ウイルスベクター＆プラスミドDNAの北米市場規模2016-2027（アメリカ、カナダ） ・ウイルスベクター＆プラスミドDNAのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ウイルスベクター＆プラスミドDNAのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ウイルスベクター＆プラスミドDNAの中南米市場規模2016-2027（メキシコ、ブラジル） ・ウイルスベクター＆プラスミドDNAの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Brammer Bio、Oxford BioMedica、Cobra Biologics、FinVector、Lonza、BioReliance、MolMed、FUJIFILM Diosynth Biotechnologies、UniQure、Aldevron、Richter-Helm、Eurogentec、OBiO Technology、Yposkesi、Cell and Gene Therapy Catapult、MassBiologics、Biovian、VGXI、Gene Synthesis、PlasmidFactory、Jikai Gene） ・結論 |
Viral vectors carry genetic material into cells by exploiting the molecular mechanisms by which viruses transmit their genomes to other cells for infection.It can occur in vivo or in vitro.Plasmid carriers are plasmids artificially constructed on the basis of natural plasmids to adapt to laboratory operations.In recent years, global viral vector and plasmid DNA manufacturing has developed rapidly, with a compound growth rate of about 28% during 2018-2018.In 2018, global sales of viral vector and plasmid DNA production reached $381 million.In 2018, China accounted for about 4% of global sales.In the next five years, the production of viral vectors and plasmid DNA products in China will continue to grow rapidly.Viral vector and plasmid DNA manufacturing are mainly divided into viral vector manufacturing and plasmid DNA manufacturing, among which viral vector manufacturing accounts for the largest proportion, accounting for nearly 38% of the total market in 2018.Viral vector and plasmid DNA manufacturing is mainly used for drug development and production of cancer, genetic diseases, viral infections and other diseases, among which cancer is the main application field, accounting for 35% in 2018.The market is highly competitive.Brammer Bio, Oxford BioMedica, Cobra Biologics, FinVector and Lonza are major suppliers.They have mastered key technologies and patents, and they have a fixed customer base. They have established a monopoly in the market.Gene therapy technology innovation and clinical trials have mushroomed in recent years, and a number of gene therapy projects have been approved for marketing in the United States, the European Union, China and other countries.The target of gene therapy has also been gradually expanded from single gene genetic diseases to malignant tumors, infectious diseases, cardiovascular diseases, autoimmune diseases, metabolic diseases and other major diseases.
Market Analysis and Insights: Global Viral Vector and Plasmid DNA Market
The global Viral Vector and Plasmid DNA market size is projected to reach US$ 1613.1 million by 2026, from US$ 469 million in 2019, at a CAGR of 19.3% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Viral Vector and Plasmid DNA market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Viral Vector and Plasmid DNA market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Viral Vector and Plasmid DNA market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Viral Vector and Plasmid DNA market.
Global Viral Vector and Plasmid DNA Scope and Market Size
Viral Vector and Plasmid DNA market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Viral Vector and Plasmid DNA market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Plasmid DNA
Viral Vector
Segment by Application
Cancer
Virus Infection
Hereditary Disease
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Brammer Bio
Oxford BioMedica
Cobra Biologics
FinVector
Lonza
BioReliance
MolMed
FUJIFILM Diosynth Biotechnologies
UniQure
FinVector
Lonza
Eurogentec
OBiO Technology
Yposkesi
Cell and Gene Therapy Catapult
MassBiologics
Biovian
VGXI
Gene Synthesis
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vector and Plasmid DNA Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Plasmid DNA
1.2.3 Viral Vector
1.3 Market by Application
1.3.1 Global Viral Vector and Plasmid DNA Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Virus Infection
1.3.4 Hereditary Disease
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Viral Vector and Plasmid DNA Market Perspective (2016-2027)
2.2 Viral Vector and Plasmid DNA Growth Trends by Regions
2.2.1 Viral Vector and Plasmid DNA Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Viral Vector and Plasmid DNA Historic Market Share by Regions (2016-2021)
2.2.3 Viral Vector and Plasmid DNA Forecasted Market Size by Regions (2022-2027)
2.3 Viral Vector and Plasmid DNA Industry Dynamic
2.3.1 Viral Vector and Plasmid DNA Market Trends
2.3.2 Viral Vector and Plasmid DNA Market Drivers
2.3.3 Viral Vector and Plasmid DNA Market Challenges
2.3.4 Viral Vector and Plasmid DNA Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vector and Plasmid DNA Players by Revenue
3.1.1 Global Top Viral Vector and Plasmid DNA Players by Revenue (2016-2021)
3.1.2 Global Viral Vector and Plasmid DNA Revenue Market Share by Players (2016-2021)
3.2 Global Viral Vector and Plasmid DNA Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Viral Vector and Plasmid DNA Revenue
3.4 Global Viral Vector and Plasmid DNA Market Concentration Ratio
3.4.1 Global Viral Vector and Plasmid DNA Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vector and Plasmid DNA Revenue in 2020
3.5 Viral Vector and Plasmid DNA Key Players Head office and Area Served
3.6 Key Players Viral Vector and Plasmid DNA Product Solution and Service
3.7 Date of Enter into Viral Vector and Plasmid DNA Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vector and Plasmid DNA Breakdown Data by Type
4.1 Global Viral Vector and Plasmid DNA Historic Market Size by Type (2016-2021)
4.2 Global Viral Vector and Plasmid DNA Forecasted Market Size by Type (2022-2027)
5 Viral Vector and Plasmid DNA Breakdown Data by Application
5.1 Global Viral Vector and Plasmid DNA Historic Market Size by Application (2016-2021)
5.2 Global Viral Vector and Plasmid DNA Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Viral Vector and Plasmid DNA Market Size (2016-2027)
6.2 North America Viral Vector and Plasmid DNA Market Size by Type
6.2.1 North America Viral Vector and Plasmid DNA Market Size by Type (2016-2021)
6.2.2 North America Viral Vector and Plasmid DNA Market Size by Type (2022-2027)
6.2.3 North America Viral Vector and Plasmid DNA Market Size by Type (2016-2027)
6.3 North America Viral Vector and Plasmid DNA Market Size by Application
6.3.1 North America Viral Vector and Plasmid DNA Market Size by Application (2016-2021)
6.3.2 North America Viral Vector and Plasmid DNA Market Size by Application (2022-2027)
6.3.3 North America Viral Vector and Plasmid DNA Market Size by Application (2016-2027)
6.4 North America Viral Vector and Plasmid DNA Market Size by Country
6.4.1 North America Viral Vector and Plasmid DNA Market Size by Country (2016-2021)
6.4.2 North America Viral Vector and Plasmid DNA Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Viral Vector and Plasmid DNA Market Size (2016-2027)
7.2 Europe Viral Vector and Plasmid DNA Market Size by Type
7.2.1 Europe Viral Vector and Plasmid DNA Market Size by Type (2016-2021)
7.2.2 Europe Viral Vector and Plasmid DNA Market Size by Type (2022-2027)
7.2.3 Europe Viral Vector and Plasmid DNA Market Size by Type (2016-2027)
7.3 Europe Viral Vector and Plasmid DNA Market Size by Application
7.3.1 Europe Viral Vector and Plasmid DNA Market Size by Application (2016-2021)
7.3.2 Europe Viral Vector and Plasmid DNA Market Size by Application (2022-2027)
7.3.3 Europe Viral Vector and Plasmid DNA Market Size by Application (2016-2027)
7.4 Europe Viral Vector and Plasmid DNA Market Size by Country
7.4.1 Europe Viral Vector and Plasmid DNA Market Size by Country (2016-2021)
7.4.2 Europe Viral Vector and Plasmid DNA Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Viral Vector and Plasmid DNA Market Size (2016-2027)
8.2 Asia-Pacific Viral Vector and Plasmid DNA Market Size by Type
8.2.1 Asia-Pacific Viral Vector and Plasmid DNA Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Viral Vector and Plasmid DNA Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Viral Vector and Plasmid DNA Market Size by Type (2016-2027)
8.3 Asia-Pacific Viral Vector and Plasmid DNA Market Size by Application
8.3.1 Asia-Pacific Viral Vector and Plasmid DNA Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Viral Vector and Plasmid DNA Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Viral Vector and Plasmid DNA Market Size by Application (2016-2027)
8.4 Asia-Pacific Viral Vector and Plasmid DNA Market Size by Region
8.4.1 Asia-Pacific Viral Vector and Plasmid DNA Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Viral Vector and Plasmid DNA Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Viral Vector and Plasmid DNA Market Size (2016-2027)
9.2 Latin America Viral Vector and Plasmid DNA Market Size by Type
9.2.1 Latin America Viral Vector and Plasmid DNA Market Size by Type (2016-2021)
9.2.2 Latin America Viral Vector and Plasmid DNA Market Size by Type (2022-2027)
9.2.3 Latin America Viral Vector and Plasmid DNA Market Size by Type (2016-2027)
9.3 Latin America Viral Vector and Plasmid DNA Market Size by Application
9.3.1 Latin America Viral Vector and Plasmid DNA Market Size by Application (2016-2021)
9.3.2 Latin America Viral Vector and Plasmid DNA Market Size by Application (2022-2027)
9.3.3 Latin America Viral Vector and Plasmid DNA Market Size by Application (2016-2027)
9.4 Latin America Viral Vector and Plasmid DNA Market Size by Country
9.4.1 Latin America Viral Vector and Plasmid DNA Market Size by Country (2016-2021)
9.4.2 Latin America Viral Vector and Plasmid DNA Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vector and Plasmid DNA Market Size (2016-2027)
10.2 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Type
10.2.1 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Type (2016-2027)
10.3 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Application
10.3.1 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Application (2016-2027)
10.4 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Country
10.4.1 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Brammer Bio
11.1.1 Brammer Bio Company Details
11.1.2 Brammer Bio Business Overview
11.1.3 Brammer Bio Viral Vector and Plasmid DNA Introduction
11.1.4 Brammer Bio Revenue in Viral Vector and Plasmid DNA Business (2016-2021)
11.1.5 Brammer Bio Recent Development
11.2 Oxford BioMedica
11.2.1 Oxford BioMedica Company Details
11.2.2 Oxford BioMedica Business Overview
11.2.3 Oxford BioMedica Viral Vector and Plasmid DNA Introduction
11.2.4 Oxford BioMedica Revenue in Viral Vector and Plasmid DNA Business (2016-2021)
11.2.5 Oxford BioMedica Recent Development
11.3 Cobra Biologics
11.3.1 Cobra Biologics Company Details
11.3.2 Cobra Biologics Business Overview
11.3.3 Cobra Biologics Viral Vector and Plasmid DNA Introduction
11.3.4 Cobra Biologics Revenue in Viral Vector and Plasmid DNA Business (2016-2021)
11.3.5 Cobra Biologics Recent Development
11.4 FinVector
11.4.1 FinVector Company Details
11.4.2 FinVector Business Overview
11.4.3 FinVector Viral Vector and Plasmid DNA Introduction
11.4.4 FinVector Revenue in Viral Vector and Plasmid DNA Business (2016-2021)
11.4.5 FinVector Recent Development
11.5 Lonza
11.5.1 Lonza Company Details
11.5.2 Lonza Business Overview
11.5.3 Lonza Viral Vector and Plasmid DNA Introduction
11.5.4 Lonza Revenue in Viral Vector and Plasmid DNA Business (2016-2021)
11.5.5 Lonza Recent Development
11.6 BioReliance
11.6.1 BioReliance Company Details
11.6.2 BioReliance Business Overview
11.6.3 BioReliance Viral Vector and Plasmid DNA Introduction
11.6.4 BioReliance Revenue in Viral Vector and Plasmid DNA Business (2016-2021)
11.6.5 BioReliance Recent Development
11.7 MolMed
11.7.1 MolMed Company Details
11.7.2 MolMed Business Overview
11.7.3 MolMed Viral Vector and Plasmid DNA Introduction
11.7.4 MolMed Revenue in Viral Vector and Plasmid DNA Business (2016-2021)
11.7.5 MolMed Recent Development
11.8 FUJIFILM Diosynth Biotechnologies
11.8.1 FUJIFILM Diosynth Biotechnologies Company Details
11.8.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.8.3 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Introduction
11.8.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector and Plasmid DNA Business (2016-2021)
11.8.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.9 UniQure
11.9.1 UniQure Company Details
11.9.2 UniQure Business Overview
11.9.3 UniQure Viral Vector and Plasmid DNA Introduction
11.9.4 UniQure Revenue in Viral Vector and Plasmid DNA Business (2016-2021)
11.9.5 UniQure Recent Development
11.10 Aldevron
11.10.1 Aldevron Company Details
11.10.2 Aldevron Business Overview
11.10.3 Aldevron Viral Vector and Plasmid DNA Introduction
11.10.4 Aldevron Revenue in Viral Vector and Plasmid DNA Business (2016-2021)
11.10.5 Aldevron Recent Development
11.11 Richter-Helm
11.11.1 Richter-Helm Company Details
11.11.2 Richter-Helm Business Overview
11.11.3 Richter-Helm Viral Vector and Plasmid DNA Introduction
11.11.4 Richter-Helm Revenue in Viral Vector and Plasmid DNA Business (2016-2021)
11.11.5 Richter-Helm Recent Development
11.12 Eurogentec
11.12.1 Eurogentec Company Details
11.12.2 Eurogentec Business Overview
11.12.3 Eurogentec Viral Vector and Plasmid DNA Introduction
11.12.4 Eurogentec Revenue in Viral Vector and Plasmid DNA Business (2016-2021)
11.12.5 Eurogentec Recent Development
11.13 OBiO Technology
11.13.1 OBiO Technology Company Details
11.13.2 OBiO Technology Business Overview
11.13.3 OBiO Technology Viral Vector and Plasmid DNA Introduction
11.13.4 OBiO Technology Revenue in Viral Vector and Plasmid DNA Business (2016-2021)
11.13.5 OBiO Technology Recent Development
11.14 Yposkesi
11.14.1 Yposkesi Company Details
11.14.2 Yposkesi Business Overview
11.14.3 Yposkesi Viral Vector and Plasmid DNA Introduction
11.14.4 Yposkesi Revenue in Viral Vector and Plasmid DNA Business (2016-2021)
11.14.5 Yposkesi Recent Development
11.15 Cell and Gene Therapy Catapult
11.15.1 Cell and Gene Therapy Catapult Company Details
11.15.2 Cell and Gene Therapy Catapult Business Overview
11.15.3 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Introduction
11.15.4 Cell and Gene Therapy Catapult Revenue in Viral Vector and Plasmid DNA Business (2016-2021)
11.15.5 Cell and Gene Therapy Catapult Recent Development
11.16 MassBiologics
11.16.1 MassBiologics Company Details
11.16.2 MassBiologics Business Overview
11.16.3 MassBiologics Viral Vector and Plasmid DNA Introduction
11.16.4 MassBiologics Revenue in Viral Vector and Plasmid DNA Business (2016-2021)
11.16.5 MassBiologics Recent Development
11.17 Biovian
11.17.1 Biovian Company Details
11.17.2 Biovian Business Overview
11.17.3 Biovian Viral Vector and Plasmid DNA Introduction
11.17.4 Biovian Revenue in Viral Vector and Plasmid DNA Business (2016-2021)
11.17.5 Biovian Recent Development
11.18 VGXI
11.18.1 VGXI Company Details
11.18.2 VGXI Business Overview
11.18.3 VGXI Viral Vector and Plasmid DNA Introduction
11.18.4 VGXI Revenue in Viral Vector and Plasmid DNA Business (2016-2021)
11.18.5 VGXI Recent Development
11.18 Gene Synthesis
.1 Gene Synthesis Company Details
.2 Gene Synthesis Business Overview
.3 Gene Synthesis Viral Vector and Plasmid DNA Introduction
.4 Gene Synthesis Revenue in Viral Vector and Plasmid DNA Business (2016-2021)
.5 Gene Synthesis Recent Development
11.20 PlasmidFactory
11.20.1 PlasmidFactory Company Details
11.20.2 PlasmidFactory Business Overview
11.20.3 PlasmidFactory Viral Vector and Plasmid DNA Introduction
11.20.4 PlasmidFactory Revenue in Viral Vector and Plasmid DNA Business (2016-2021)
11.20.5 PlasmidFactory Recent Development
11.21 Jikai Gene
11.21.1 Jikai Gene Company Details
11.21.2 Jikai Gene Business Overview
11.21.3 Jikai Gene Viral Vector and Plasmid DNA Introduction
11.21.4 Jikai Gene Revenue in Viral Vector and Plasmid DNA Business (2016-2021)
11.21.5 Jikai Gene Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Viral Vector and Plasmid DNA Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Plasmid DNA
Table 3. Key Players of Viral Vector
Table 4. Global Viral Vector and Plasmid DNA Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Viral Vector and Plasmid DNA Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Viral Vector and Plasmid DNA Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Viral Vector and Plasmid DNA Market Share by Regions (2016-2021)
Table 8. Global Viral Vector and Plasmid DNA Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Viral Vector and Plasmid DNA Market Share by Regions (2022-2027)
Table 10. Viral Vector and Plasmid DNA Market Trends
Table 11. Viral Vector and Plasmid DNA Market Drivers
Table 12. Viral Vector and Plasmid DNA Market Challenges
Table 13. Viral Vector and Plasmid DNA Market Restraints
Table 14. Global Viral Vector and Plasmid DNA Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Viral Vector and Plasmid DNA Market Share by Players (2016-2021)
Table 16. Global Top Viral Vector and Plasmid DNA Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vector and Plasmid DNA as of 2020)
Table 17. Ranking of Global Top Viral Vector and Plasmid DNA Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Viral Vector and Plasmid DNA Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Viral Vector and Plasmid DNA Product Solution and Service
Table 21. Date of Enter into Viral Vector and Plasmid DNA Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Viral Vector and Plasmid DNA Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Viral Vector and Plasmid DNA Revenue Market Share by Type (2016-2021)
Table 25. Global Viral Vector and Plasmid DNA Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Viral Vector and Plasmid DNA Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Viral Vector and Plasmid DNA Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Viral Vector and Plasmid DNA Revenue Market Share by Application (2016-2021)
Table 29. Global Viral Vector and Plasmid DNA Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Viral Vector and Plasmid DNA Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Viral Vector and Plasmid DNA Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Viral Vector and Plasmid DNA Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Viral Vector and Plasmid DNA Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Viral Vector and Plasmid DNA Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Viral Vector and Plasmid DNA Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Viral Vector and Plasmid DNA Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Viral Vector and Plasmid DNA Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Viral Vector and Plasmid DNA Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Viral Vector and Plasmid DNA Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Viral Vector and Plasmid DNA Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Viral Vector and Plasmid DNA Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Viral Vector and Plasmid DNA Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Viral Vector and Plasmid DNA Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Viral Vector and Plasmid DNA Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Viral Vector and Plasmid DNA Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Viral Vector and Plasmid DNA Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Viral Vector and Plasmid DNA Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Viral Vector and Plasmid DNA Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Viral Vector and Plasmid DNA Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Viral Vector and Plasmid DNA Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Viral Vector and Plasmid DNA Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Viral Vector and Plasmid DNA Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Viral Vector and Plasmid DNA Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Viral Vector and Plasmid DNA Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Viral Vector and Plasmid DNA Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Viral Vector and Plasmid DNA Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Viral Vector and Plasmid DNA Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Viral Vector and Plasmid DNA Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Viral Vector and Plasmid DNA Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Viral Vector and Plasmid DNA Market Size by Country (2022-2027) & (US$ Million)
Table 61. Brammer Bio Company Details
Table 62. Brammer Bio Business Overview
Table 63. Brammer Bio Viral Vector and Plasmid DNA Product
Table 64. Brammer Bio Revenue in Viral Vector and Plasmid DNA Business (2016-2021) & (US$ Million)
Table 65. Brammer Bio Recent Development
Table 66. Oxford BioMedica Company Details
Table 67. Oxford BioMedica Business Overview
Table 68. Oxford BioMedica Viral Vector and Plasmid DNA Product
Table 69. Oxford BioMedica Revenue in Viral Vector and Plasmid DNA Business (2016-2021) & (US$ Million)
Table 70. Oxford BioMedica Recent Development
Table 71. Cobra Biologics Company Details
Table 72. Cobra Biologics Business Overview
Table 73. Cobra Biologics Viral Vector and Plasmid DNA Product
Table 74. Cobra Biologics Revenue in Viral Vector and Plasmid DNA Business (2016-2021) & (US$ Million)
Table 75. Cobra Biologics Recent Development
Table 76. FinVector Company Details
Table 77. FinVector Business Overview
Table 78. FinVector Viral Vector and Plasmid DNA Product
Table 79. FinVector Revenue in Viral Vector and Plasmid DNA Business (2016-2021) & (US$ Million)
Table 80. FinVector Recent Development
Table 81. Lonza Company Details
Table 82. Lonza Business Overview
Table 83. Lonza Viral Vector and Plasmid DNA Product
Table 84. Lonza Revenue in Viral Vector and Plasmid DNA Business (2016-2021) & (US$ Million)
Table 85. Lonza Recent Development
Table 86. BioReliance Company Details
Table 87. BioReliance Business Overview
Table 88. BioReliance Viral Vector and Plasmid DNA Product
Table 89. BioReliance Revenue in Viral Vector and Plasmid DNA Business (2016-2021) & (US$ Million)
Table 90. BioReliance Recent Development
Table 91. MolMed Company Details
Table 92. MolMed Business Overview
Table 93. MolMed Viral Vector and Plasmid DNA Product
Table 94. MolMed Revenue in Viral Vector and Plasmid DNA Business (2016-2021) & (US$ Million)
Table 95. MolMed Recent Development
Table 96. FUJIFILM Diosynth Biotechnologies Company Details
Table 97. FUJIFILM Diosynth Biotechnologies Business Overview
Table 98. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector and Plasmid DNA Business (2016-2021) & (US$ Million)
Table 99. FUJIFILM Diosynth Biotechnologies Recent Development
Table 100. UniQure Company Details
Table 101. UniQure Business Overview
Table 102. UniQure Viral Vector and Plasmid DNA Product
Table 103. UniQure Revenue in Viral Vector and Plasmid DNA Business (2016-2021) & (US$ Million)
Table 104. UniQure Recent Development
Table 105. Aldevron Company Details
Table 106. Aldevron Business Overview
Table 107. Aldevron Viral Vector and Plasmid DNA Product
Table 108. Aldevron Revenue in Viral Vector and Plasmid DNA Business (2016-2021) & (US$ Million)
Table 109. Aldevron Recent Development
Table 110. Richter-Helm Company Details
Table 111. Richter-Helm Business Overview
Table 112. Richter-Helm Viral Vector and Plasmid DNA Product
Table 113. Richter-Helm Revenue in Viral Vector and Plasmid DNA Business (2016-2021) & (US$ Million)
Table 114. Richter-Helm Recent Development
Table 115. Eurogentec Company Details
Table 116. Eurogentec Business Overview
Table 117. Eurogentec Viral Vector and Plasmid DNA Product
Table 118. Eurogentec Revenue in Viral Vector and Plasmid DNA Business (2016-2021) & (US$ Million)
Table 119. Eurogentec Recent Development
Table 120. OBiO Technology Company Details
Table 121. OBiO Technology Business Overview
Table 122. OBiO Technology Viral Vector and Plasmid DNA Product
Table 123. OBiO Technology Revenue in Viral Vector and Plasmid DNA Business (2016-2021) & (US$ Million)
Table 124. OBiO Technology Recent Development
Table 125. Yposkesi Company Details
Table 126. Yposkesi Business Overview
Table 127. Yposkesi Viral Vector and Plasmid DNA Product
Table 128. Yposkesi Revenue in Viral Vector and Plasmid DNA Business (2016-2021) & (US$ Million)
Table 129. Yposkesi Recent Development
Table 130. Cell and Gene Therapy Catapult Company Details
Table 131. Cell and Gene Therapy Catapult Business Overview
Table 132. Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Product
Table 133. Cell and Gene Therapy Catapult Revenue in Viral Vector and Plasmid DNA Business (2016-2021) & (US$ Million)
Table 134. Cell and Gene Therapy Catapult Recent Development
Table 135. MassBiologics Company Details
Table 136. MassBiologics Business Overview
Table 137. MassBiologics Viral Vector and Plasmid DNA Product
Table 138. MassBiologics Revenue in Viral Vector and Plasmid DNA Business (2016-2021) & (US$ Million)
Table 139. MassBiologics Recent Development
Table 140. Biovian Company Details
Table 141. Biovian Business Overview
Table 142. Biovian Viral Vector and Plasmid DNA Product
Table 143. Biovian Revenue in Viral Vector and Plasmid DNA Business (2016-2021) & (US$ Million)
Table 144. Biovian Recent Development
Table 145. VGXI Company Details
Table 146. VGXI Business Overview
Table 147. VGXI Viral Vector and Plasmid DNA Product
Table 148. VGXI Revenue in Viral Vector and Plasmid DNA Business (2016-2021) & (US$ Million)
Table 149. VGXI Recent Development
Table 150. Gene Synthesis Company Details
Table 151. Gene Synthesis Business Overview
Table 152. Gene Synthesis Viral Vector and Plasmid DNA Product
Table 153. Gene Synthesis Revenue in Viral Vector and Plasmid DNA Business (2016-2021) & (US$ Million)
Table 154. Gene Synthesis Recent Development
Table 155. PlasmidFactory Company Details
Table 156. PlasmidFactory Business Overview
Table 157. PlasmidFactory Viral Vector and Plasmid DNA Product
Table 158. PlasmidFactory Revenue in Viral Vector and Plasmid DNA Business (2016-2021) & (US$ Million)
Table 159. PlasmidFactory Recent Development
Table 160. Jikai Gene Company Details
Table 161. Jikai Gene Business Overview
Table 162. Jikai Gene Viral Vector and Plasmid DNA Product
Table 163. Jikai Gene Revenue in Viral Vector and Plasmid DNA Business (2016-2021) & (US$ Million)
Table 164. Jikai Gene Recent Development
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Vector and Plasmid DNA Market Share by Type: 2020 VS 2027
Figure 2. Plasmid DNA Features
Figure 3. Viral Vector Features
Figure 4. Global Viral Vector and Plasmid DNA Market Share by Application: 2020 VS 2027
Figure 5. Cancer Case Studies
Figure 6. Virus Infection Case Studies
Figure 7. Hereditary Disease Case Studies
Figure 8. Viral Vector and Plasmid DNA Report Years Considered
Figure 9. Global Viral Vector and Plasmid DNA Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Viral Vector and Plasmid DNA Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Viral Vector and Plasmid DNA Market Share by Regions: 2020 VS 2027
Figure 12. Global Viral Vector and Plasmid DNA Market Share by Regions (2022-2027)
Figure 13. Global Viral Vector and Plasmid DNA Market Share by Players in 2020
Figure 14. Global Top Viral Vector and Plasmid DNA Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vector and Plasmid DNA as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Viral Vector and Plasmid DNA Revenue in 2020
Figure 16. Global Viral Vector and Plasmid DNA Revenue Market Share by Type (2016-2021)
Figure 17. Global Viral Vector and Plasmid DNA Revenue Market Share by Type (2022-2027)
Figure 18. North America Viral Vector and Plasmid DNA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Viral Vector and Plasmid DNA Market Share by Type (2016-2027)
Figure 20. North America Viral Vector and Plasmid DNA Market Share by Application (2016-2027)
Figure 21. North America Viral Vector and Plasmid DNA Market Share by Country (2016-2027)
Figure 22. United States Viral Vector and Plasmid DNA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Viral Vector and Plasmid DNA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Viral Vector and Plasmid DNA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Viral Vector and Plasmid DNA Market Share by Type (2016-2027)
Figure 26. Europe Viral Vector and Plasmid DNA Market Share by Application (2016-2027)
Figure 27. Europe Viral Vector and Plasmid DNA Market Share by Country (2016-2027)
Figure 28. Germany Viral Vector and Plasmid DNA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Viral Vector and Plasmid DNA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Viral Vector and Plasmid DNA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Viral Vector and Plasmid DNA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Viral Vector and Plasmid DNA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Viral Vector and Plasmid DNA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Viral Vector and Plasmid DNA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Viral Vector and Plasmid DNA Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Viral Vector and Plasmid DNA Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Viral Vector and Plasmid DNA Market Share by Region (2016-2027)
Figure 38. China Viral Vector and Plasmid DNA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Viral Vector and Plasmid DNA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Viral Vector and Plasmid DNA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Viral Vector and Plasmid DNA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Viral Vector and Plasmid DNA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Viral Vector and Plasmid DNA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Viral Vector and Plasmid DNA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Viral Vector and Plasmid DNA Market Share by Type (2016-2027)
Figure 46. Latin America Viral Vector and Plasmid DNA Market Share by Application (2016-2027)
Figure 47. Latin America Viral Vector and Plasmid DNA Market Share by Country (2016-2027)
Figure 48. Mexico Viral Vector and Plasmid DNA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Viral Vector and Plasmid DNA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Viral Vector and Plasmid DNA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Viral Vector and Plasmid DNA Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Viral Vector and Plasmid DNA Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Viral Vector and Plasmid DNA Market Share by Country (2016-2027)
Figure 54. Turkey Viral Vector and Plasmid DNA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Viral Vector and Plasmid DNA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Viral Vector and Plasmid DNA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Brammer Bio Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2016-2021)
Figure 58. Oxford BioMedica Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2016-2021)
Figure 59. Cobra Biologics Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2016-2021)
Figure 60. FinVector Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2016-2021)
Figure 61. Lonza Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2016-2021)
Figure 62. BioReliance Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2016-2021)
Figure 63. MolMed Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2016-2021)
Figure 64. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2016-2021)
Figure 65. UniQure Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2016-2021)
Figure 66. Aldevron Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2016-2021)
Figure 67. Richter-Helm Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2016-2021)
Figure 68. Eurogentec Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2016-2021)
Figure 69. OBiO Technology Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2016-2021)
Figure 70. Yposkesi Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2016-2021)
Figure 71. Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2016-2021)
Figure 72. MassBiologics Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2016-2021)
Figure 73. Biovian Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2016-2021)
Figure 74. VGXI Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2016-2021)
Figure 75. Gene Synthesis Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2016-2021)
Figure 76. PlasmidFactory Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2016-2021)
Figure 77. Jikai Gene Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2016-2021)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
世界のウイルスベクター＆プラスミドDNA製造市場規模・現状・予測（2021年-2027年） The viral vectors and plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases. Based on classification, the proportion of Viral Vectors Manufacturing in 2016 is about 79.74%, with revenue about 200 M USD. Based on application, Cancers segment accoun…- 世界のウイルスベクター製造市場規模・現状・予測（2021年-2027年） Viral vectors represent one of the primary tools, which can be used to deliver the genetic material into cells. Viral vectors can be utilized in gene therapy for the treatment of different diseases, such as heart defects, metabolic diseases, cancer, and neurodegenerative disorders. Viral vectors bas…
- 世界のインフルエンザウイルスベクターワクチン市場規模・現状・予測（2021年-2027年） The virus-sensitive vector vaccine, which is characterized by nasal drip vaccination, is currently undergoing safety and efficacy studies in experimental animals. In 2021, the global Influenza Virus Vector Vaccine market size will be US$ XX million and it is expected to reach US$ XX million by the e…
- 世界のプラスミド市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Plasmid Market The global Plasmid market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt t…
- 世界のベクトル信号発生器市場規模・現状・予測（2021年-2027年） Vector signal generator is a test and measurement equipment used for testing complex waveforms. This equipment was developed considering the emergence of new communication technologies and consists of a high-end radio-frequency (RF) signal generator with an IQ modulator. According to the report, the…